330 related articles for article (PubMed ID: 10127361)
1. Joint ventures become even riskier.
Azevedo D
Med Econ; 1993 Jul; 70(14):36-8, 41, 44-5. PubMed ID: 10127361
[No Abstract] [Full Text] [Related]
2. Joint ventures: still unclear waters.
Weissburg C; Conn LC
Health Syst Rev; 1992; 25(2):40-2. PubMed ID: 10116880
[No Abstract] [Full Text] [Related]
3. "Hanlester Laboratories": HHS joint venture standards remain unclear.
Tully WB
Healthspan; 1991 Nov; 8(10):8-11. PubMed ID: 10114943
[No Abstract] [Full Text] [Related]
4. HHS publishes long-awaited fraud and abuse anti-kickback regulations.
Weissburg C; Conn LC
Rev Fed Am Health Syst; 1989; 22(2):45-7. PubMed ID: 10303427
[No Abstract] [Full Text] [Related]
5. "Fraud alert": joint venture arrangements.
Vipperman RM
Med Staff Couns; 1989; 3(4):57-61. PubMed ID: 10303857
[TBL] [Abstract][Full Text] [Related]
6. Legal issues in physician self-referral and other health care business relationships.
Tedrick S
J Leg Med; 1992 Dec; 13(4):521-61. PubMed ID: 1469331
[No Abstract] [Full Text] [Related]
7. Special report. HHS IG's final "safe harbor" recommendations: more exemptions--and more strings.
Health Policy Week; 1989 Nov; 18(42):suppl 1-6. PubMed ID: 10304221
[No Abstract] [Full Text] [Related]
8. The Medicare & Medicaid anti-kickback statute and the safe harbor regulations--what's next?
Kusserow RP
Health Matrix Clevel; 1992; 2(1):49-70. PubMed ID: 10122467
[No Abstract] [Full Text] [Related]
9. Safe harbors for toy boats: an analysis and commentary.
Peregrine MW; Waller AA; Glaser DL
J Health Hosp Law; 1991 Oct; 24(10):297-310, 319, 328. PubMed ID: 10114556
[No Abstract] [Full Text] [Related]
10. Hanlester Laboratories decision: important test of antikickback statute.
Tully WB
Healthspan; 1991 Apr; 8(4):9-12. PubMed ID: 10110667
[No Abstract] [Full Text] [Related]
11. The impact of fraud and abuse regulations.
Mackelvie CF; Handler MS; Sanborn AB
Healthc Financ Manage; 1992 Oct; 46(10):26-30, 32-3. PubMed ID: 10145687
[TBL] [Abstract][Full Text] [Related]
12. Hanlester Laboratories decision gives dangerously broad interpretation of federal anti-kickback statute.
Tully WB; Wirth PH
Healthspan; 1992 Jun; 9(6):11-4. PubMed ID: 10183678
[No Abstract] [Full Text] [Related]
13. Stark's crusade: the Ethics in Patient Referrals Act of 1989.
Morse RA; Popovits RM
J Health Hosp Law; 1989 Jul; 22(7):208-16, 224. PubMed ID: 10304214
[No Abstract] [Full Text] [Related]
14. Proposed restrictions on physician referrals to clinical labs: important areas left unclarified.
Cooney PE
Healthspan; 1992 May; 9(5):3-7. PubMed ID: 10119529
[No Abstract] [Full Text] [Related]
15. Update: fraud and abuse and Stark laws.
Steiner JE
J Health Hosp Law; 1993 Sep; 26(9):274-82, 288. PubMed ID: 10136108
[No Abstract] [Full Text] [Related]
16. The Ethics in Patient Referrals Act of 1989: an analysis of the bill and the issue.
Lindeke JM; Solomon JE
Med Staff Couns; 1989; 3(3):1-7. PubMed ID: 10303628
[TBL] [Abstract][Full Text] [Related]
17. SmithKline settles charges of kickbacks at 3 labs.
Burda D
Mod Healthc; 1989 Dec; 19(52):3. PubMed ID: 10304218
[No Abstract] [Full Text] [Related]
18. HHS IG's final "safe harbor" recommendations: more exemptions--and more strings.
Part B News; 1989 Nov; 3(15):suppl 1-4. PubMed ID: 10304045
[No Abstract] [Full Text] [Related]
19. Perspectives. Lawmakers block that kickback.
Mcgraw Hills Med Health; 1989 Apr; 43(13):suppl 4 p.. PubMed ID: 10303316
[No Abstract] [Full Text] [Related]
20. The growing crackdown on laboratory fraud and abuse.
Albertson D
MLO Med Lab Obs; 1991 Feb; 23(2):24-9. PubMed ID: 10109602
[No Abstract] [Full Text] [Related]
[Next] [New Search]
